BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26186432)

  • 21. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
    Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
    Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
    Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
    Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
    Xiong GL; Fiuzat M; Kuchibhatla M; Krishnan R; O'Connor CM; Jiang W;
    Circ Heart Fail; 2012 Nov; 5(6):688-92. PubMed ID: 23065038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation and depressive phenotypes: evidence from medical records from over 12 000 patients and brain morphology.
    Ironside M; Admon R; Maddox SA; Mehta M; Douglas S; Olson DP; Pizzagalli DA
    Psychol Med; 2020 Dec; 50(16):2790-2798. PubMed ID: 31615590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
    Fourrier C; Sampson E; Mills NT; Baune BT
    Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased inflammation predicts nine-year change in major depressive disorder diagnostic status.
    Zainal NH; Newman MG
    J Abnorm Psychol; 2021 Nov; 130(8):829-840. PubMed ID: 34618490
    [No Abstract]   [Full Text] [Related]  

  • 29. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD.
    Gregg LP; Carmody T; Le D; Bharadwaj N; Trivedi MH; Hedayati SS
    Kidney360; 2020 Jun; 1(6):436-446. PubMed ID: 35368605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and markers of inflammation as predictors of all-cause mortality in heart failure.
    Mommersteeg PMC; Schoemaker RG; Naudé PJW; Eisel ULM; Garrelds IM; Schalkwijk CG; Westerhuis BWJJM; Kop WJ; Denollet J
    Brain Behav Immun; 2016 Oct; 57():144-150. PubMed ID: 27013355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional counselling in adults promoting adherence to the Mediterranean diet as adjuvant in the treatment of major depressive disorder (INDEPT): a randomized open controlled trial study protocol.
    Sousa-Santos N; Fialho M; Madeira T; Clara C; Veiga S; Martins R; Barros N; Santos G; Santos O; Almeida C; Ganança L; Campos RC; Camolas J; da Silva AP; Guarino MPS; Heitor MJ
    BMC Psychiatry; 2023 Apr; 23(1):227. PubMed ID: 37016319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressive symptoms and inflammatory biomarkers in patients with heart failure.
    Dekker RL; Moser DK; Tovar EG; Chung ML; Heo S; Wu JR; Dunbar SB; Pressler SJ; Lennie TA
    Eur J Cardiovasc Nurs; 2014 Oct; 13(5):444-50. PubMed ID: 24062026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
    Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines.
    Al-Hakeim HK; Twayej AJ; Al-Dujaili AH; Maes M
    CNS Neurol Disord Drug Targets; 2020; 19(1):44-54. PubMed ID: 31894751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study.
    Alves TC; Rays J; Telles RM; Júnior RF; Wajngarten M; Romano BW; Watanabe C; Busatto GF
    Psychosomatics; 2007; 48(1):22-30. PubMed ID: 17209146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. trans fatty acids and systemic inflammation in heart failure.
    Mozaffarian D; Rimm EB; King IB; Lawler RL; McDonald GB; Levy WC
    Am J Clin Nutr; 2004 Dec; 80(6):1521-5. PubMed ID: 15585763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
    Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH
    J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.